These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


250 related items for PubMed ID: 23771511

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
    Kim YH, Oh SW, Lim YJ, Park CK, Lee SH, Kang KW, Jung HW, Chang KH.
    Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Glioma grading by dynamic susceptibility contrast perfusion and 11C-methionine positron emission tomography using different regions of interest.
    Brendle C, Hempel JM, Schittenhelm J, Skardelly M, Reischl G, Bender B, Ernemann U, la Fougère C, Klose U.
    Neuroradiology; 2018 Apr; 60(4):381-389. PubMed ID: 29464269
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic accuracy of 13N-ammonia PET, 11C-methionine PET and 18F-fluorodeoxyglucose PET: a comparative study in patients with suspected cerebral glioma.
    He Q, Zhang L, Zhang B, Shi X, Yi C, Zhang X.
    BMC Cancer; 2019 Apr 08; 19(1):332. PubMed ID: 30961564
    [Abstract] [Full Text] [Related]

  • 7. Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading.
    Wu R, Watanabe Y, Arisawa A, Takahashi H, Tanaka H, Fujimoto Y, Watabe T, Isohashi K, Hatazawa J, Tomiyama N.
    Jpn J Radiol; 2017 Oct 08; 35(10):613-621. PubMed ID: 28879406
    [Abstract] [Full Text] [Related]

  • 8. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
    Ideguchi M, Nishizaki T, Ikeda N, Okamura T, Tanaka Y, Fujii N, Ohno M, Shimabukuro T, Kimura T, Ikeda E, Suga K.
    J Neurooncol; 2018 Jul 08; 138(3):537-548. PubMed ID: 29516344
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Substitution of 11C-methionine PET by perfusion MRI during the follow-up of treated high-grade gliomas: preliminary results in clinical practice.
    Dandois V, Rommel D, Renard L, Jamart J, Cosnard G.
    J Neuroradiol; 2010 May 08; 37(2):89-97. PubMed ID: 19570578
    [Abstract] [Full Text] [Related]

  • 11. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
    Yamaguchi S, Terasaka S, Kobayashi H, Narita T, Hirata K, Shiga S, Usui R, Tanaka S, Kubota K, Murata J, Asaoka K.
    No Shinkei Geka; 2010 Jul 08; 38(7):621-8. PubMed ID: 20628188
    [Abstract] [Full Text] [Related]

  • 12. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA, Henze M, Tüttenberg J, Stieltjes B, Meissner M, Zimmer F, Burkholder I, Kroll A, Combs SE, Vogt-Schaden M, Giesel FL, Zoubaa S, Haberkorn U, Kauczor HU, Essig M.
    Invest Radiol; 2010 Dec 08; 45(12):755-68. PubMed ID: 20829706
    [Abstract] [Full Text] [Related]

  • 13. Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation.
    Roessler K, Gatterbauer B, Becherer A, Paul M, Kletter K, Prayer D, Hoeftberger R, Hainfellner J, Asenbaum S, Knosp E.
    Minim Invasive Neurosurg; 2007 Oct 08; 50(5):273-80. PubMed ID: 18058643
    [Abstract] [Full Text] [Related]

  • 14. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.
    Hatakeyama T, Kawai N, Nishiyama Y, Yamamoto Y, Sasakawa Y, Ichikawa T, Tamiya T.
    Eur J Nucl Med Mol Imaging; 2008 Nov 08; 35(11):2009-17. PubMed ID: 18542957
    [Abstract] [Full Text] [Related]

  • 15. Non-invasive assessment of heterogeneity of gliomas using diffusion and perfusion MRI: correlation with spatially co-registered PET.
    Zhang Y, Lin Y, Xing Z, Yao S, Cao D, Miao WB.
    Acta Radiol; 2022 May 08; 63(5):664-671. PubMed ID: 33858207
    [Abstract] [Full Text] [Related]

  • 16. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K, Nyáry I, Tóth M, Ericson K, Gulyás B.
    J Neurol Sci; 2006 Jul 15; 246(1-2):85-94. PubMed ID: 16603193
    [Abstract] [Full Text] [Related]

  • 17. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH, Thomas A, Kracht LW, Li H, Dittmar C, Garlip G, Galldiks N, Klein JC, Sobesky J, Hilker R, Vollmar S, Herholz K, Wienhard K, Heiss WD.
    J Nucl Med; 2005 Dec 15; 46(12):1948-58. PubMed ID: 16330557
    [Abstract] [Full Text] [Related]

  • 18. [(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas.
    Collet S, Valable S, Constans JM, Lechapt-Zalcman E, Roussel S, Delcroix N, Abbas A, Ibazizene M, Bernaudin M, Barré L, Derlon JM, Guillamo JS.
    Neuroimage Clin; 2015 Dec 15; 8():448-54. PubMed ID: 26106569
    [Abstract] [Full Text] [Related]

  • 19. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
    Gumprecht H, Grosu AL, Souvatsoglou M, Dzewas B, Weber WA, Lumenta CB.
    Zentralbl Neurochir; 2007 Feb 15; 68(1):19-23. PubMed ID: 17487804
    [Abstract] [Full Text] [Related]

  • 20. 11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas.
    D'Souza MM, Sharma R, Jaimini A, Panwar P, Saw S, Kaur P, Mondal A, Mishra A, Tripathi RP.
    Clin Nucl Med; 2014 Sep 15; 39(9):791-8. PubMed ID: 25036022
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.